Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06267014

Acronym

Cog-RV

Enrollment

Registered

2024-02-20

Start date

2024-05-23

Completion date

2026-02-06

Last updated

2026-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Cancer-related Cognitive Difficulties

Keywords

virtual reality, cognitive rehabilitation

Brief summary

The study concerns patients who have been treated for breast cancer, have cognitive problems and are planning to return to work or are currently working and wish to begin cognitive rehabilitation. Patients will follow the Virtual Reality program developed for the study, during the cognitive rehabilitation usually proposed in the establishment, at the rate of a weekly session of 10-15 minute for 6 weeks.

Interventions

BEHAVIORALVirtual Reality sessions

One session during 10-15 minutes per week for 6 weeks.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Intervention model description

Patients will follow the Virtual Reality program developed for the study, during the cognitive rehabilitation sessions

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients \>18 years of age * Patient with breast cancer for whom adjuvant chemotherapy has been administered; maintenance treatments (e.g. Trastuzumab, hormone therapy) are eligible, * Maximum 2 years after completion of adjuvant treatment, * Patients who have cognitive complaints at inclusion (answer yes to the question: 'Since your cancer treatment, have you had any difficulties with memory, concentration, etc.?) * Patients planning to return to work or who have returned to work in the past year, * Signature of informed consent prior to any specific procedure relating to the study, * Patient affiliated to a social security system.

Exclusion criteria

* Patients suffering from illnesses or conditions that impair their ability to understand, follow and/or comply with study procedures, * Patients with personality disorders and/or psychiatric pathology, * Patients deprived of their liberty or placed under the authority of a guardian, * Pregnant women

Design outcomes

Primary

Measure	Time frame	Description
Proportion of patients adhering to the Virtual Reality program	At 6 weeks	Adherence is defined as the completion of at least 5 of the 6 sessions planned.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026